•
Mar 30

Teleflex Q1 2025 Earnings Report

Reported First Quarter 2025 Financial Results

Key Takeaways

Teleflex reported a decrease in revenue for the first quarter of 2025 compared to the prior year, driven by declines in the EMEA and Asia segments and the OEM product category. Despite this, the company saw growth in Vascular Access, Interventional, Surgical, and Other product categories. GAAP EPS increased significantly while Adjusted Diluted EPS decreased.

Revenues of $700.7 million, down 5.0% compared to the prior year period.

GAAP diluted EPS from continuing operations was $2.07, a significant increase from $0.33 in the prior year period.

Adjusted diluted EPS from continuing operations was $2.91, compared to $3.21 in the prior year period.

The company is exploring strategic options for the separation of Teleflex into two independent publicly traded companies.

Total Revenue
$701M
Previous year: $738M
-5.0%
EPS
$2.91
Previous year: $3.21
-9.3%
Interest Expense
$18.5M
Previous year: $22.7M
-18.2%
Depreciation and Amortization
$68.2M
Previous year: $66.9M
+1.9%
Gross Profit
$389M
Previous year: $416M
-6.4%
Cash and Equivalents
$284M
Previous year: $237M
+19.7%
Total Assets
$7.16B
Previous year: $7.48B
-4.2%

Teleflex

Teleflex

Teleflex Revenue by Segment

Teleflex Revenue by Geographic Location

Forward Guidance

Teleflex is raising its full year 2025 GAAP revenue growth guidance and maintaining its adjusted constant currency revenue growth guidance. The company is lowering its GAAP and adjusted diluted EPS guidance due to the impact of tariffs and separation/acquisition-related expenses, partially offset by share repurchases and expense control.

Positive Outlook

  • Raising full year 2025 GAAP revenue growth guidance range to 1.28% to 2.28%.
  • Maintaining adjusted constant currency revenue growth guidance range of 1.00% to 2.00%.
  • Completed a $300 million accelerated share repurchase.
  • Evaluating strategies to mitigate exposure to tariffs.
  • Actively exploring options for the NewCo separation, including a potential sale, to maximize shareholder value.

Challenges Ahead

  • Lowering GAAP EPS from continuing operations guidance range to $6.51 to $6.91 due to tariffs and separation/acquisition-related expenses.
  • Lowering adjusted diluted EPS from continuing operations guidance range to $13.20 to $13.60 due to tariffs.
  • Expect an impact from tariffs of approximately $55 million in 2025.
  • Separation and acquisition-related expenses are impacting GAAP EPS guidance.
  • Adjusted diluted EPS guidance represents a decrease of 5.8% to 2.9% year-over-year.

Revenue & Expenses

Visualization of income flow from segment revenue to net income